Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Stephen E. Goldstone. (2023) Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Wei (Vivian) Wang, Smita Kothari, Jozica Skufca, Anna R. Giuliano, Karin Sundström, Mari Nygård, Carol Koro, Marc Baay, Thomas Verstraeten, Alain Luxembourg, Alfred J. Saah & Suzanne M. Garland. (2022) Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review. Expert Review of Vaccines 21:12, pages 1799-1817.
Read now
Read now
Wei Wang, Smita Kothari, Marc Baay, Suzanne M. Garland, Anna R. Giuliano, Mari Nygård, Christine Velicer, Joseph Tota, Anushua Sinha, Jozica Skufca, Thomas Verstraeten & Karin Sundström. (2022) Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources. Expert Review of Vaccines 21:2, pages 227-240.
Read now
Read now
Nathalie Grün, Andreas Ährlund-Richter, Joar Franzén, Leila Mirzaie, Lena Marions, Torbjörn Ramqvist & Tina Dalianis. (2016) Follow-up on oral and cervical human papillomavirus prevalence 2013–2015 in youth at a youth clinic in Stockholm, Sweden. Infectious Diseases 48:2, pages 169-170.
Read now
Read now
Articles from other publishers (22)
Liba Sokolovska, Maria Isaguliants & Franco M. Buonaguro. (2023) Proceedings of the Online Conference “Vaccines and Vaccination during and Post COVID Pandemics” (7–9 December 2022). Vaccines 11:7, pages 1175.
Crossref
Crossref
C. Badoual, Y. Adimi, J. Martin, B. Morin & R. Baudouin. (2023) Les cancers des voies aérodigestives supérieures induits par une infection par Papillomavirus humain : spécificités épidémiologiques, diagnostiques, pronostiques et thérapeutiques. Bulletin de l'Académie Nationale de Médecine 207:3, pages 295-302.
Crossref
Crossref
Filip Rob, Jan Hugo, Martina Saláková, Jana Šmahelová, Spyridon Gkalpakiotis, Petr Boháč & Ruth Tachezy. (2022) Prevalence of genital and oral human papillomavirus infection among psoriasis patients on biologic therapy. Dermatologic Therapy 35:10.
Crossref
Crossref
Anna R. Giuliano, Timothy Wilkin, Oliver M. Bautista, Kyeongmi Cheon, Laurie Connor, Sheri Dubey, Alain Luxembourg, Sonali Rawat, Anita Shaw, Christine Velicer, Neika Vendetti & Yingmei Tu. (2022) Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men. Contemporary Clinical Trials 115, pages 106592.
Crossref
Crossref
Kelsey H. Jordan, Chloe M. Beverly Hery, Xiaochen Zhang & Electra D. Paskett. (2022) Low Rates of Dual-Site and Concordant Oral-Cervical Human Papillomavirus Infections and Cancers: A Systematic Review. Frontiers in Oncology 12.
Crossref
Crossref
Joanna Katarzyna Strzelczyk, Krzysztof Biernacki, Jadwiga Gaździcka, Elżbieta Chełmecka, Katarzyna Miśkiewicz-Orczyk, Natalia Zięba, Janusz Strzelczyk & Maciej Misiołek. (2021) The Prevalence of High- and Low-Risk Types of HPV in Patients with Squamous Cell Carcinoma of the Head and Neck, Patients with Chronic Tonsillitis, and Healthy Individuals Living in Poland. Diagnostics 11:12, pages 2180.
Crossref
Crossref
Juan Du, Andreas Ährlund-Richter, Anders Näsman & Tina Dalianis. (2020) Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008–2018, and perspectives on cancer prevention. Archives of Gynecology and Obstetrics 303:2, pages 329-335.
Crossref
Crossref
A. Näsman, J. Du & T. Dalianis. (2019) A global epidemic increase of an HPV‐induced tonsil and tongue base cancer – potential benefit from a pan‐gender use of HPV vaccine. Journal of Internal Medicine 287:2, pages 134-152.
Crossref
Crossref
Ioannis Mammas, Tina Dalianis, Sotiros Doukas, Apostolos Zaravinos, Vassilis Achtsidis, Prakash Thiagarajan, Maria Theodoridou & Demetrios Spandidos. (2019) Paediatric virology and human papillomaviruses: An update. Experimental and Therapeutic Medicine.
Crossref
Crossref
Małgorzata Wierzbicka, Johannes Hans Berkhof & Frederik G. Dikkers. (2019) Prophylactic human papilloma virus vaccination in head and neck: indications and future perspectives. Current Opinion in Otolaryngology & Head & Neck Surgery 27:2, pages 85-90.
Crossref
Crossref
Samantha Tam, Shuangshuang Fu, Li Xu, Kate J. Krause, David R. Lairson, Hongyu Miao, Erich M. Sturgis & Kristina R. Dahlstrom. (2018) The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis. Oral Oncology 82, pages 91-99.
Crossref
Crossref
Justin M. Hintze & James P. O’Neill. (2018) Strengthening the case for gender-neutral and the nonavalent HPV vaccine. European Archives of Oto-Rhino-Laryngology 275:4, pages 857-865.
Crossref
Crossref
Talía Malagón, Ann Burchell, Mariam El-Zein, Julie Guénoun, Pierre-Paul Tellier, François Coutlée & Eduardo L. Franco. (2018) Y Chromosome DNA in Women's Vaginal Samples as a Biomarker of Recent Vaginal Sex and Condom Use With Male Partners in the HPV Infection and Transmission Among Couples Through Heterosexual Activity Cohort Study. Sexually Transmitted Diseases 45:1, pages 28-34.
Crossref
Crossref
Somayeh Pouyanfard & Martin Müller. (2017) Human papillomavirus first and second generation vaccines–current status and future directions. Biological Chemistry 398:8, pages 871-889.
Crossref
Crossref
Ulrike Wieland. (2017) Impfung birgt großes Potenzial. Der Deutsche Dermatologe 65:4, pages 272-284.
Crossref
Crossref
Stephan Herberhold, Martin Hellmich, Marcus Panning, Eva Bartok, Steffi Silling, Baki Akgül & Ulrike Wieland. (2016) Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma. Medical Microbiology and Immunology 206:2, pages 93-103.
Crossref
Crossref
Valentina Lupato, Dana Holzinger, Daniela Höfler, Anna Menegaldo, Paolo Giorgi Rossi, Annarosa Del Mistro, Maria Cristina Da Mosto, Michael Pawlita & Paolo Boscolo-Rizzo. (2017) Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy. PLOS ONE 12:1, pages e0170091.
Crossref
Crossref
Stina Syrjänen & Jaana Rautava. 2017. HPV Infection in Head and Neck Cancer. HPV Infection in Head and Neck Cancer
257
267
.
David I. Conway, Chris Robertson, Heather Gray, Linda Young, Lisa M. McDaid, Andrew J. Winter, Christine Campbell, Jiafeng Pan, Kimberley Kavanagh, Sharon Kean, Ramya Bhatia, Heather Cubie, Jan E. Clarkson, Jeremy Bagg, Kevin G. Pollock & Kate Cuschieri. (2016) Human Papilloma Virus (HPV) Oral Prevalence in Scotland (HOPSCOTCH): A Feasibility Study in Dental Settings. PLOS ONE 11:11, pages e0165847.
Crossref
Crossref
Hideo SHIGEISHI, Masaru SUGIYAMA, Kouji OHTA, Mohammad Zeshaan RAHMAN & Masaaki TAKECHI. (2016) Higher prevalence and gene amplification of HPV16 in oropharynx as compared to oral cavity. Journal of Applied Oral Science 24:4, pages 397-403.
Crossref
Crossref
A Handisurya, C Schellenbacher, A Haitel, T Senger & R Kirnbauer. (2016) Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids. British Journal of Cancer 114:4, pages 409-416.
Crossref
Crossref
Torbjörn Ramqvist, Nathalie Grün & Tina Dalianis. (2015) Human Papillomavirus and Tonsillar and Base of Tongue Cancer. Viruses 7:3, pages 1332-1343.
Crossref
Crossref